Company News for Nov 25, 2025
Werte in diesem Artikel
Shares of CureVac N.V. (CVAC) rose 1.6% after reporting third-quarter 2025 adjusted loss of $0.10 per share, narrower than the Zacks Consensus Estimate of a loss of $0.17 per share.Corporación América Airports S.A.’s (CAAP) shares gained 1.6% after posting third-quarter 2025 revenues of $532.10 million, beating the Zacks Consensus Estimate of $491.50 million. Novo Nordisk A/S’s (NVO) shares tumbled 5.6% after the clinical trial of its Alzheimer’s disease failed to meet the primary target of slowing progression.Shares of Alibaba Group Holding Ltd. (BABA) surged 5.1% after the company announced that its AI-app, Qwen, had witnessed 10 million downloads within its first week of launching.Beyond Nvidia: AI's Second Wave Is HereThe AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. Little-known AI firms tackling the world's biggest problems may be more lucrative in the coming months and years.See "2nd Wave" AI stocks now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Novo Nordisk A/S (NVO): Free Stock Analysis Report Alibaba Group Holding Limited (BABA): Free Stock Analysis Report Corporacion America Airports S.A. (CAAP): Free Stock Analysis Report CureVac N.V. (CVAC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: NOV und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf NOV
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf NOV
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Quelle: Zacks
Nachrichten zu NOV Inc Registered Shs
Analysen zu NOV Inc Registered Shs
Keine Analysen gefunden.